Minaris is a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities.

Pharmaron, founded in 2004, is a leading life sciences service provider offering research, development, and manufacturing across drug discovery and clinical development for small molecules, biologics, and CGT. With 22,000+ staff, it operates in China, the U.S., and the U.K.

Asemblis is a Swiss biotech company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development.